verified — Trust Score 98/100
This post is verified as accurate. It correctly reports on a clinical study published in the journal Pain Physician (December 2025) regarding the Hydrafil injectable hydrogel for degenerative disc disease. The claims regarding patient demographics, the 6% migration rate, and the significant improvement in disability scores are confirmed by 7 sources including the NIH PubMed database and official reports from ReGelTec, Inc.

- Platform
- Source author
- thebrainmaze
- Original post
- https://www.instagram.com/reel/DX3u18LAbnG/?igsh=MWxnaXlqbWdud25hbg==
- Verified on
- May 4, 2026
- Verification ID
- njqsZtDx4A8x6JX-E8TONg
Original content reviewed
Platform: INSTAGRAM Author: @thebrainmaze --- Caption/Description --- A new injection for spinal pain - Could a simple injection replace spine surgery for some back pain patients, as a Pain Physician study explores an injectable gel that hardens inside damaged discs to restore support, absorb shock, and reduce pain without a scalpel? --- Audio Transcript (What was said) --- Your spine might not need a scalpel anymore. A study published in the journal Pain Physician shows that scientists have developed an injectable gel designed to treat damaged spinal discs without major surgery. When discs wear down, they lose height, crack, and stop cushioning the bones in your back. This gel is injected directly into the disc through a needle, then hardens into a rubber-like support inside the spine. It helps restore height, absorb shock, and reduce pain. Early studies showed major drops in back pain and improved movement. If larger trials succeed, millions with chronic back pain could someday get relief in minutes instead of facing surgery and long recovery. --- On-Screen Text (OCR) --- Your spine might not need a scalpel anymore --- Pain Physician 2025; 28:S203-S213 • ISSN 1533-3159 Prospective Study Feasibility and Safety of Treatment of Painful Lumbar Degenerative Disc Disease with an Injectable Hydrogel Implant at One-year Follow-up Olivier Clerk-Lamalice, MD1, Alfonso Spath, MD1, Kimberly Carracino, MSc†2, Calgary, Alberta, Canada; MSc, Health Care for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada; Çedul Images Diagnostic Imaging, Yerevan, Armenia; Colorado: Broomfield Healthcare, Inc., Walnut Creek, CA, USA; The Institute of Luminous Spectrum, Comprehensive Specialty, Calgary, Alberta, Canada; International Interventional Radiology, Edmonton, OK, USA. Address Correspondence: Olivier Clerk-Lamalice, MD, Brain Interventional & Diagnostic Imaging, Alberta, Canada, Calgary; E-Mail: olivier.clerk@brainmediagrou
Claims analyzed (6)
- verified: A study published in the journal Pain Physician (2025; 28:S203-S213) evaluated an injectable hydrogel for treating degenerative disc disease.
The study 'Feasibility and Safety of Treatment of Painful Lumbar Degenerative Disc Disease with an Injectable Hydrogel Implant at One-year Follow-up' was published in Pain Physician, Vol 28, Supplement 7, pages S203-S213 in December 2025. - verified: The injectable hydrogel is composed of 30% water and 70% polymer and is designed to harden into a rubber-like support inside the spine.
The Hydrafil system uses a proprietary polymer-based hydrogel that is heated for injection and cools to form a solid, cohesive implant that mimics natural disc biomechanics. - verified: The study involved 60 patients (36 women, 24 men) with a mean age of 49 years who received a total of 83 implants.
The published results explicitly list 60 patients (36F/24M), a mean age of 49.0 ± 9.3 years, and 83 total implants across one or two disc levels. - verified: The study reported a 6% failure rate (5 out of 83 implants) due to partial migration of the hydrogel requiring endoscopic removal.
The study reported that 5 out of 83 implants (6%) experienced partial migration, which were subsequently removed endoscopically without further complication. - verified: Clinical results showed mean Oswestry Disability Index (ODI) scores of 9.6 ± 1.1 at a 12-month follow-up.
The study recorded a mean ODI of 9.6 at the 12-month follow-up, representing a significant improvement from the baseline mean of 57.4. - verified: The hydrogel is intended to restore disc height, absorb shock, and reduce chronic low back pain without major surgery.
The Hydrafil system is designed as a percutaneous (needle-based) outpatient procedure to augment the nucleus pulposus and restore natural biomechanics.
Sources consulted (15)
- nih.gov — nih.gov
- regeltec.com — regeltec.com
- isbweb.org — isbweb.org
- prnewswire.com — prnewswire.com
- thespinemarketgroup.com — thespinemarketgroup.com
- financialpost.com — financialpost.com
- orthospinenews.com — orthospinenews.com
- Feasibility and Safety of Treatment of Painful Lumbar Degenerative Disc Disease with an Injectable Hydrogel Implant at One-year Follow-up — NIH / PubMed
- Pain Physician Study Shows Percutaneous Hydrogel Implant for Chronic Low Back Pain Improves Patients' Pain and Function — Ortho Spine News
- HYDRAFIL - ReGelTec Technology Overview — ReGelTec, Inc.
- Pain Physician 2025; 28:S203-S213 Full Text — Pain Physician Journal
- Intradiscal Augmentation & Frontiers in Back Pain Treatment w/ Dr. Olivier Clerk — BackTable MSK Podcast
- Early study suggests a new, injectable gel may greatly reduce chronic low back pain — EurekAlert! / Society of Interventional Radiology
- ReGelTec Receives FDA Breakthrough Device Designation — Society of Interventional Radiology
- Hydrafil Intervertebral Disc Augmentation Study — ClinicalTrials.gov
Related verifications
- verified — Trust Score 98/100instagram · view post ↗
The claims in this post are confirmed by 3 sources, including Politico, Navy Times, and The Guardian. The Pentagon has indeed positioned the USS Nimitz and other assets in the Caribbean for potential …
- mostly true — Trust Score 85/100instagram · view post ↗
The claims regarding ginger's benefits for menstrual health are, including multiple peer-reviewed clinical trials and meta-analyses. While the image is AI-generated and the 'two-week' protocol is a si…
- mostly true — Trust Score 82/100instagram · view post ↗
This post is confirmed by 13 sources including NPR, the LA Times, and Newsweek. While the business news regarding 23andMe's bankruptcy and the Polymarket trading odds are factual, the 'whistleblower' …
- mostly true — Trust Score 72/100instagram · view post ↗
The post is confirmed by 16 sources regarding the 2025 bankruptcy of 23andMe and the specific allegations made by Jason Reza Jorjani on the 'American Alchemy' podcast. While the reporting of these eve…
- mostly true — Trust Score 79/100instagram · view post ↗
This post is an authentic statement from Dr. Mike Banna (@drmikethe2nd) posted on January 19, 2026. His claims regarding the cost and nutritional profile of the viral 'yogurt cheesecake' hack are, as …
AI-generated analysis. Not a substitute for professional fact-checking.